The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Nwosu, Benjamin Udoka ^a   Maranda, Louise ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; HEMOGLOBIN A1C; INSULIN; METFORMIN; VITAMIN D; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; BODY WEIGHT; DIET SUPPLEMENTATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIVER DISEASE; METABOLISM; PATHOPHYSIOLOGY;

ADOLESCENT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER DISEASES; MALE; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84903398617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099646     Document Type: Article

References (63)

1. (1995) Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75: 894-903.
2. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, et al. (2007) Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 18: 235-243. (Pubitemid 46053436)
3. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853.
4. Petitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, et al. (2009) Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth Study. J Pediatr 155: 668-672.
5. Heinemann L (2010) New ways of insulin delivery. Int J Clin Pract Suppl: 29-40.
6. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, et al. (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118: 1388-1393. (Pubitemid 46393782)
7. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, et al. (2006) Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91: 4287-4294. (Pubitemid 44833400)
8. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, et al. (2003) Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143: 500-505. (Pubitemid 37352510)
9. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, et al. (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9: 85.
10. Manco M, Ciampalini P, Nobili V (2010) Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 51: 2229; author reply 2230.
11. Cusi K (2009) Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 16: 141-149.
12. Zelber-Sagi S, Lotan R, Shibolet O, Webb M, Buch A, et al. (2013) Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int 33: 1406-1412.
13. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, et al. (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32: 741-750.
14. Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost HG, et al. (2008) Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31: 1138-1143.
15. Monami M, Bardini G, Lamanna C, Pala L, Cresci B, et al. (2008) Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 57: 387-392. (Pubitemid 351178729)
16. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, et al. (2010) Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 10: 56.
17. Ali R, Cusi K (2009) New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ann Med 41: 265-278.
18. Sung KC, Wild SH, Byrne CD (2013) Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab 98: 3637-3643.
19. Liangpunsakul S, Chalasani N (2011) Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci 56: 2124-2129.
20. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889-1895. (Pubitemid 34564303)
21. Nadeau KJ, Klingensmith G, Zeitler P (2005) Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 41: 94-98. (Pubitemid 40967362)
22. Nwosu BU, Stavre ZG, Maranda L, Cullen K, Lee MM (2012) Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. J Pediatr Endocrinol Metab 25: 181-186.
23. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820-825. (Pubitemid 41103882)
24. Greer RM, Portelli SL, Hung BS, Cleghorn GJ, McMahon SK, et al. (2013) Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr Diabetes 14: 31-41.
25. Svoren BM, Volkening LK, Wood JR, Laffel LM (2009) Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 154: 132-134.
26. Drincic AT, Armas LA, Van Diest EE, Heaney RP (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 20: 1444-1448.
27. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH (1988) Low circulating vitamin D in obesity. Calcif Tissue Int 43: 199-201.
28. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, et al. (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338: 867-872. (Pubitemid 28135963)
29. Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS (2011) A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 96: 447-452.
30. Aljabri KS, Bokhari SA, Khan MJ (2010) Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med 30: 454-458.
31. Ostergard M, Arnberg K, Michaelsen KF, Madsen AL, Krarup H, et al. (2011) Vitamin D status in infants: relation to nutrition and season. Eur J Clin Nutr 65: 657-660.
32. Drincic A, Fuller E, Heaney RP, Armas LA (2013) 25-hydroxyvitamin d response to graded vitamin d3 supplementation among obese adults. J Clin Endocrinol Metab 98: 4845-4851.
33. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, et al. (2000) CDC growth charts: United States. Adv Data: 1-27.
34. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, et al. (2005) Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 6: 13-16. (Pubitemid 40514886)
35. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930.
36. Thomas DE, Elliott EJ, Naughton GA (2006) Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD002968.
37. Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM (2006) Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 29: 174. (Pubitemid 44033461)
38. Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P (2013) Vitamin D and glycemic control in diabetes mellitus type 2. Ther Adv Endocrinol Metab 4: 122-128.
39. Hypponen E, Power C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29: 2244-2246. (Pubitemid 44899859)
40. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40: 344-347. (Pubitemid 27096561)
41. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, et al. (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114: 577-583. (Pubitemid 46087264)
42. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500-1503. (Pubitemid 33055701)
43. (1999) Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 42: 51-54.
44. Kositsawat J, Freeman VL, Gerber BS, Geraci S (2010) Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey. Diabetes Care 33: 1236-1238.
45. Perez-Ferre N, Torrejon MJ, Fuentes M, Fernandez MD, Ramos A, et al. (2012) Association of low serum 25-hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes. Endocr Pract 18: 676-684.
46. von Hurst PR, Stonehouse W, Coad J (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 103: 549-555.
47. Nagpal J, Pande JN, Bhartia A (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26: 19-27.
48. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320-325. (Pubitemid 351322698)
49. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, et al. (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112-2119.
50. Jorde R, Figenschau Y (2009) Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48: 349-354.
51. Strobel F, Reusch J, Penna-Martinez M, Ramos-Lopez E, Klahold E, et al. (2013) Effect of a Randomised Controlled Vitamin D Trial on Insulin Resistance and Glucose Metabolism in Patients with Type 2 Diabetes Mellitus. Horm Metab Res.
52. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, et al. (2011) Daily consumption of vitamin D- or vitamin D+calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93: 764-771.
53. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, et al. (2012) Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev 28: 424-430.
54. Ryu OH, Lee S, Yu J, Choi MG, Yoo HJ, et al. (2013) A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J.
55. Grineva EN, Karonova T, Micheeva E, Belyaeva O, Nikitina IL (2013) Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging (Albany NY) 5: 575-581.
56. Ortega RM, Lopez-Sobaler AM, Aparicio A, Bermejo LM, Rodriguez-Rodriguez E, et al. (2009) Vitamin D status modification by two slightly hypocaloric diets in young overweight/obese women. Int J Vitam Nutr Res 79: 71-78.
57. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89: 1321-1327.
58. Sun X, Zemel MB (2008) 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. Int J Obes (Lond) 32: 1305-1311.
59. Zemel MB, Sun X (2008) Calcitriol and energy metabolism. Nutr Rev 66: S139-146.
60. Christakos S, Norman AW (1979) Studies on the mode of action of calciferol. XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreas. Biochem Biophys Res Commun 89: 56-63. (Pubitemid 9237022)
61. Norman AW, Frankel JB, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825. (Pubitemid 10017495)
62. Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28: 1228-1230. (Pubitemid 40616645)
63. Scragg R, Sowers M, Bell C (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813-2818. (Pubitemid 39565042)